Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026)

Ardelyx's (ARDX) quarterly Cash from Investing Activities came in at -$10.0 million in Q1 2026, down 450.58% YoY from $2.9 million in Q1 2025, and down 364.7% on a QoQ basis from $3.8 million in Q4 2025.

Ardelyx (ARDX) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Ardelyx (ARDX) has 14 years of Cash from Investing Activities data on file, last reported at -$10.0 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 450.58% year-over-year to -$10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.8 million (down 69.1% YoY) and the FY2025 annual result came in at -$9.0 million, up 51.09% from the prior year.
  • Cash from Investing Activities slipped to -$10.0 million in Q1 2026, from $3.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $34.9 million in Q2 2025 to a low of -$59.2 million in Q2 2023.
  • A 5-year average of -$8.8 million and a median of -$832000.0 in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities tumbled 3829.93% — and 2025, when it jumped 210.85%.
  • Tracing ARDX's Cash from Investing Activities over 5 years: stood at $1.4 million in 2022, then slumped by 2151.84% to -$29.6 million in 2023, then sank by 40.77% to -$41.6 million in 2024, then surged by 109.07% to $3.8 million in 2025, then slumped by 364.7% to -$10.0 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$10.0 million (Q1 2026), $3.8 million (Q4 2025), and -$50.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -1.66 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -49.35 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 19.77 Mn
7 Royalty Pharma 33.72 Bn 35.84 Bn - -229.72 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -363.46 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 24.51 Mn
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn 22.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 22.66 Mn
Jun 30, 2026 22.66 Mn
Mar 31, 2026 -10.00 Mn
Mar 31, 2026 -10.00 Mn
Dec 31, 2025 3.78 Mn
Dec 31, 2025 3.78 Mn
Sep 30, 2025 -50.51 Mn
Sep 30, 2025 -50.51 Mn
Jun 30, 2025 34.92 Mn
Jun 30, 2025 34.92 Mn
Mar 31, 2025 2.85 Mn
Mar 31, 2025 2.85 Mn
Dec 31, 2024 -41.62 Mn
Dec 31, 2024 -41.62 Mn
Sep 30, 2024 2.34 Mn
Sep 30, 2024 2.34 Mn
Jun 30, 2024 23.53 Mn
Jun 30, 2024 23.53 Mn
Mar 31, 2024 -2.57 Mn
Mar 31, 2024 -2.57 Mn